Awardee OrganizationUNIVERSITY OF PITTSBURGH AT PITTSBURGH
Description
Abstract Text
The Administrative Core will enable the whole to be greater than the parts by fostering a scientific environment
that promotes the overall CORT objectives: advancing understanding of systemic sclerosis (SSc)
pathogenesis, to identifying new biomarkers of disease, and discovering novel therapies for patients with SSc.
Dr. Robert Lafyatis will lead the CORT as Program Director and chair the Executive Committee, composed of
the directors and associate directors of each of the projects and cores with Dr. Robyn Domsic the Program
Associate Director. Dr. Oliver Eickelberg, U Pitt Vice Chair for Basic and Translational Science (project 2, PI);
Dr. Stephen Chan, Director, Center for Pulmonary Vascular Biology and Medicine (project 3, PI); and Dr.
Harinder Singh, Director of the Center for Systems Immunology (Core C, PI) will provide additional leadership
experience for the Executive Committee. The administrative core will organize Executive Committee meetings
every other month that will serve both as a time to discuss administrative organization, but more importantly a
time for scientific exchange between investigators. The Administrative Core will assemble a highly-experienced
external Advisory Committee composed of physician-scientists, working in the areas of CORT projects and
cores: SSc skin disease, interstitial lung disease, pulmonary arterial hypertension, biomarkers, systems biology
and clinical outcomes. This committee will annually review each project and core, critiquing progress, probing
obstacles, and providing advice for new scientific directions. The CORT Administrative Core will manage
budgets, arrange meetings of the Executive and Advisory committees, assist the CORT director in preparing
reports, manage the website, solicit and organize review of Pilot and Feasibility proposals, and arrange
enrichment seminars. The Center will organize the structures needed for robust communication in order to
advance the science of the interdisciplinary groups composing the Center. The Administrative Core will provide
enrichment opportunities for CORT investigators through invited speakers; solicit and organize Advisory
Committee evaluation of Pilot and Feasibility Grants, targeting young, early stage and minority investigators;
and organize mentoring for minority, young, early stage investigators
Public Health Relevance Statement
The CORT Administrative Core will foster a scientific environment that promotes CORT goals advancing
understanding of systemic sclerosis pathogenesis, identifying new biomarkers of disease, and discovering
novel therapies for patients with SSc. A strong leadership team will organize and manage CORT investigator,
project and core activities to promote this mission. An external advisory committee will provide oversight and
guidance in new scientific directions..
NIH Spending Category
No NIH Spending Category available.
Project Terms
Advisory CommitteesAreaBasic ScienceBiological MarkersBiologyBlood VesselsBostonBudgetsClinicalCollaborationsCommunicationCritiquesDiseaseEnsureEnvironmentEvaluationFosteringGoalsGrantHuman ResourcesImmunologyIndividualInterstitial Lung DiseasesLeadershipLungMedicineMentorsMinorityMissionNational Institute of Arthritis, and Musculoskeletal, and Skin DiseasesOutcomePathogenesisPatientsPhysiciansProgram ReviewsRecommendationReportingResearch PersonnelScienceScientistSiteSkinSystemSystemic SclerodermaSystems BiologyTimeTranslational ResearchUniversitiesbiomarker identificationclinical translationexperiencemeetingsminority investigatornovel therapeuticsorganizational structureprogramspulmonary arterial hypertensionskin disordertranslational studyweb site
National Institute of Arthritis and Musculoskeletal and Skin Diseases
CFDA Code
DUNS Number
004514360
UEI
MKAGLD59JRL1
Project Start Date
20-September-2022
Project End Date
31-August-2027
Budget Start Date
01-September-2024
Budget End Date
31-August-2025
Project Funding Information for 2024
Total Funding
$190,800
Direct Costs
$120,000
Indirect Costs
$70,800
Year
Funding IC
FY Total Cost by IC
2024
National Institute of Arthritis and Musculoskeletal and Skin Diseases
$190,800
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5P50AR080612-03 9032
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5P50AR080612-03 9032
Patents
No Patents information available for 5P50AR080612-03 9032
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5P50AR080612-03 9032
Clinical Studies
No Clinical Studies information available for 5P50AR080612-03 9032
News and More
Related News Releases
No news release information available for 5P50AR080612-03 9032
History
No Historical information available for 5P50AR080612-03 9032
Similar Projects
No Similar Projects information available for 5P50AR080612-03 9032